The outcomes revealed that CCNA2, TOP2A, AURKA, CCNB2, CDK2, CHEK1, and other potential central targets were therapeutic targets for RR treatment of ESCC. The gene discussed is CHEK1; the disease is esophageal squamous cell carcinoma.